Hela Abroug
University of Monastir
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hela Abroug.
International Journal of Cardiology | 2017
Asma Sriha Belguith; Afifa Koubaa Abdelkafi; Sana El Mhamdi; Manel Ben Fredj; Hela Abroug; Arwa Ben Salah; I. Bouanene; Fahima Hassine; Amal Amara; Sana Bhiri; Abdelkarim Derbel; Habib Gamra; Faouzi Maatouk; M. Soltani
BACKGROUND The penicillin therapy of β hemolytic streptococcal pharyngitis has aided in the decrease of rheumatic heart disease (RHD) in developing countries. Tunisia is an endemic area, however, and incidence of RHD is weakly documented. We aimed at establishing the standardized incidence rate (SIR) of RHD in Monastir governorate and at determining RHD prevalence among hospitalized patients in two cardiology departments. METHODS From the regional register of Monastir Hospital morbidity, we have selected newly diagnosed patients with RHD, residents of Monastir, and hospitalized to the 2 cardiology departments between 2000 and 2013 (2001 not included). FINDINGS We studied 676 newly admitted patients. We estimate 1060 to be the number of new annual RHD cases in Tunisia. The SIR per 105 person-years was 10.97, being 9.3 in men and 19.1 in women, respectively. We have notified a negative trend of crude incidence rate/105 Inhabitants (Inh) (CIR) (r=-0.23, p<10-3), and a strong positive correlation between age and CIR/105 Inh (r=0.989, p<10-4). RHD lethality was 1%. We have registered 728 hospitalizations for RHD, representing 2.5% of all cardiology hospitalizations [95% CI: 2.3-2.7%], with a prevalence for 13.3% for women aged 15-29years. The median hospital stay was 9days (IQR: 5-15). CONCLUSION Our results confirm the RHD incidence decrease, consistent with epidemiological transition in Tunisia. We have also emphasized on the close trend of RHD with age and the predominance of RHD among women especially at the procreation age.
International Journal of Infectious Diseases | 2017
Manel Ben Fredj; Asma Sriha Belguith; Hela Abroug; Wafa Dhouib; Sana El Mhamdi; Arwa Ben Salah; I. Bouanene; Amal Amara; Sana Bhiri; Mounira Sahtout; Chawki Loussaief; M. Soltani
BACKGROUND In spite of the epidemiological transition, communicable diseases remain a public health problem and represent a significant cause of morbidity and mortality worldwide, especially in developing countries. This study aimed to determine the crude and standardized prevalence rates of hospitalizations for communicable disease (HCD) and to assess trends in HCD by age and sex at a university hospital in Tunisia over a period of 12 years (2002-2013). METHODS All cases of HCD from 2002 to 2013 in the university hospital departments were included. Data collected from the regional register of hospital morbidity were used. The discharge diagnoses were coded according to the International Classification of Diseases, 10th revision (ICD-10). RESULTS HCD represented 17.45% of all hospitalizations during the study period (34 289/196 488; 95% confidence interval 17.28-17.62%). The median age at the time of admission was 31 years (interquartile range (IQR) 15-52 years). The median hospital length of stay (LOS) was 5days (IQR 3-9 days). The crude prevalence rate (CPR) was 5.41 per 1000 inhabitants. The CPR was highest among patients aged ≥65 years. The four communicable disease categories that represented 70% of all HCD were abdominal infection, skin infection, genitourinary infection, and lower respiratory tract infection. The majority of HCD decreased over time; however, there was a significant increase in HIV diseases, tuberculosis, and viral hepatitis. CONCLUSION This study provides evidence of the epidemiological transition, showing a decline in communicable diseases, which needs to be sustained and improved.
bioRxiv | 2018
Wafa Dhouib; Meriem Kacem; Grira Samia; Issam Maalel; I. Zemni; Hela Abroug; Arwa Ben Salah; Souhir Chelly; Amira Djobbi; Essia Green; Asma Sriha Belguith
Background: In 2016, the first global health sector strategy on viral hepatitis was endorsed with the goal of eliminating viral hepatitis as a public health threat by 2030. In Tunisia, effective vaccines for hepatitis B (HBV) have been added to the expanded programme of immunization (EPI) since July 1995 for new borns. We expected to have a decreasing trend in the prevalence rate of reported HBV. Our study aimed to address the epidemiological profile of HBV, to assess trends by age and gender in Monastir governorate over a period of 18 years according to immunization status and to estimate the burden (years lived with disability YLDs) of this pathology. Methods: We performed a descriptive cross sectional study of declared HBV from January 1, 2000 to December 31, 2017 defined as having positive serologic markers for HBs Ag. All declared patients were residents of Monastir’s Governorate. EPI included two periods, the first between 1995 and 2006 following a three-dose schedule (3, 4, 9 months). The second PI cohort after 2006 following a three-dose schedule (0, 2, 6 months). Results: During 18 years, 1526 cases of HBV were declared in Monastir with a mean of 85 cases per year. We estimated a mean of 1699 declared cases per year of HBV in Tunisia. CPR was 16.85/100,000 inh being the higher in age group of 20-39 years and in men .ASR was 15.99/100,000 inh, being 35.5 in men and 8.69 in women. During the study period, declared cases among presumed immunized (PI) person against HBV were 32(2.0%). Among PI cases, 29 were from the first period and 3 were from the second. We established a negative trend over 18 years of hepatitis B. The age group of 20 to 39 was the most common with a sharply decline. Presumed not immunized (PNI) HBV cases are decreasing by years with a prediction of 35 cases in 2024. Reported HBV contributed to 1.26 YLDs per 100,000 inh. The highest rate of YLDs occurred at the age 20-39 (2.73 YLDs per 100,000 inh). During 18 years, YLDs were 114.45 in Monastir with a mean of 2293.65 YLDs of HBV in Tunisia. Conclusion, this study showed a law prevalence rate and a decreasing trend of HBV during 18 years showing an efficacy of immunization and confirming that the universal hepatitis B vaccination in Tunisia has resulted in progress towards the prevention and control of hepatitis B infection. These findings should be demonstrated in other Tunisian regions with a standardized serological profile.
Journal of Public Health | 2018
Sana El Mhamdi; Andrine Lemieux; Hela Abroug; Arwa Ben Salah; I. Bouanene; Kamel Ben Salem; Mustafa al’Absi
Background We sought to investigate the relationship between social violence and adult overweight/obesity and the role of common mental disorders (CMD) in mediating this relationship. Methods A cross-sectional study was conducted from January to June 2016 in Tunisia. Participants were selected from randomly selected Primary Health Care Centers. The Arabic version of the Adverse Childhood Experiences-International Questionnaire (ACE-IQ) was used. Results A total of 2120 participants were included. Women exposed to social ACEs had higher rates of overweight/obesity than men (13.5 versus 9.5%; P = 0.004). For women, statistically significant partial mediation effects of CMD were observed for exposure to community violence (% mediated = 17.7%). For men, partial mediation was found for the exposure to peer violence (% mediated = 12.5%). Conclusion Our results provide evidence of the independent increase of overweight/obesity after exposure to social ACEs. Efforts to uncover and address underlying trauma in health care settings may increase the effectiveness of obesity interventions.
Revue D Epidemiologie Et De Sante Publique | 2016
M. Ben Rejeb; Hela Abroug; S. Khefacha-Aissa; M. Ben Fredj; L. Dhidah; H. Said-Latiri
Revue D Epidemiologie Et De Sante Publique | 2018
M. Ben Fredj; Hela Abroug; I. Zemni; I. Bouanene; S. El Mhamdi; A. Belguith Sriha
Revue D Epidemiologie Et De Sante Publique | 2018
Hela Abroug; M. Ben Fredj; I. Zemni; I. Bouanene; A. Ben Salah; A. Sriha Belguith
Revue D Epidemiologie Et De Sante Publique | 2018
I. Zemni; Hela Abroug; M. Ben Fredj; I. Bouanene; S. El Mhamdi; A. Belguith Sriha
Revue D Epidemiologie Et De Sante Publique | 2018
I. Zemni; M. Ben Fredj; Hela Abroug; A. Ben Salah; S. El Mhamdi; A. Belguith Sriha
Journal of Research and Development | 2018
Sawssen Bargaoui; Hela Abroug; Manel Ben Fredj; I. Zemni; Sana Bhiri; MoniaYoussef; Asma Sriha Belguith